In a letter sent to the US Securities and Exchange Commission (SEC) on 4 March, the FDA confirmed that it had paused the company’s mRNA-vaccine trial. Credit: Shutterstock / frank60. The US Food and ...

The safety and efficacy study recruited 32 healthy adults ranging in body weight from healthy weight to overweight. Credit: Shutterstock / leolintang. Bloom Science’s trial examining its primary ...

PepGen’s stock, which is listed on the Nasdaq market, dropped by 18% after the company announced the news. Image credit: Andrii Yalanskyi / Shutterstock PepGen is pausing the initiation of a new Phase ...

Biohaven’s pipeline drug BHV-7000 has failed to meet the primary endpoint in a pivotal Phase II/III bipolar trial.

The announcement comes after Pliant confirmed in February 2025 that it would pause the trial awaiting the monitoring board’s decision. Credit: Shutterstock / Lisa F Young Pliant Therapeutics has ...

The Phase I trial is currently underway in Australia, with plans to extend into the US and China. Credit: Volha_R/Shutterstock. CStone Pharmaceuticals has dosed the first subject in the multicentre ...

DESTINY-Gastric04 claims to be the first Phase III trial to evaluate the ADC in HER2-positive advanced gastric cancer. Credit: SewCreamStudio / Shutterstock. Daiichi Sankyo and AstraZeneca’s Enhertu ...

Amgen and AstraZeneca have reported outcomes from the WAYPOINT trial of Tezspire for treating chronic rhinosinusitis with ...

Most PV patients need a regular phlebotomy, which is a blood-removing process for managing increased haematocrit levels. Credit: Orawan Pattarawimonchai / Shutterstock. Takeda and Protagonist ...

The Phase II dose-finding, placebo-controlled Progress study (NCT06203002) enrolled 600 patients living with DPNP. Credit: Shutterstock / Lia_Russy. Lexicon Pharmaceuticals’ non-opioid-based therapy ...

The company plans to push ahead with its Essential3 trial programme, despite indications it will fail to meet its endpoints. Credit: Shutterstock / R Photography Background. US-based Praxis Precision ...

The Phase I trial will recruit approximately 98 healthy volunteers and adults living with atopic dermatitis at a single site ...